Id proteins in epithelial cells

Experimental Cell Research

Volumn 285, Issue 1, 2003, Pages 131-145

  Coppé, Jean Philippe ^a   Smith, Andrew P ^a   Desprez, Pierre Yves ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HELIX LOOP HELIX PROTEIN; INHIBITOR OF DIFFERENTIATION PROTEIN; PROTEIN; REGULATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HLH; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL TYPE; COLON; EMBRYO DEVELOPMENT; ENDOMETRIUM; EPIDERMIS; EPITHELIUM; EPITHELIUM CELL; ESOPHAGUS; GASTROINTESTINAL TRACT; HOMEOSTASIS; HUMAN; KIDNEY; LIVER; MAMMARY GLAND; NONHUMAN; OROPHARYNX; OVARY; PANCREAS; PANCREAS CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROSTATE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECTUM; REGULATORY MECHANISM; RESPIRATORY SYSTEM; SMALL INTESTINE; TESTIS; THYROID GLAND; URINARY TRACT; UTERINE CERVIX;

MAMMALIA;

EID: 0037446022     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(03)00014-4     Document Type: Article

References (156)

1. Murre C., McCaw P.S., Baltimore D. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell. 56:1989;777-783.
2. Yokota Y. Id and development. Oncogene. 20:2001;8290-8298.
3. Massari M.E., Murre C. Helix-loop-helix proteins regulators of transcription in eucaryotic organisms . Mol. Cell. Biol. 20:2000;429-440.
4. Campuzano S. Emc, a negative HLH regulator with multiple functions in Drosophila development. Oncogene. 20:2001;B299-B307.
5. Atchley W.R., Fitch W.M. A natural classification of the basic helix-loop-helix class of transcription factors. Proc. Natl. Acad. Sci. USA. 94:1997;5172-5176.
6. Andres-Barquin P.J., Hernandez M.C., Israel M.A. Id genes in nervous system development. Histol. Histopathol. 15:2000;603-618.
7. Benezra R., Rafii S., Lyden D. The Id proteins and angiogenesis. Oncogene, 20:2001;8334-8341.
8. Benezra R. The Id proteins targets for inhibiting tumor cells and their blood supply . Biochim. Biophys. Acta. 1551:2001;F39-F47.
9. Engel I., Murre C. The function of E- and Id proteins in lymphocyte development. Nat. Rev. Immunol. 1:2001;193-199.
10. Benezra R. Role of Id proteins in eye and tumor angiogenesis. Trends Cardiovasc. Med. 11:2001;232-241.
11. Jen Y., Manova K., Benezra R. Expression patterns of Id1, Id2, and Id3 are highly related but distinct from that of Id4 during mouse embryogenesis. Dev. Dyn. 207:1996;235-252.
12. Lyden D., Young A.Z., Zagzag D., Yan W., Gerald W., O'Reilly R., Bader B.L., Hynes R.O., Zhuang Y., Manova K., Benezra R. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature. 401:1999;670-677.
13. Norton J.D., Deed R.W., Craggs G., Sablitzky F. Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell. Biol. 8:1998;58-65.
14. Norton J.D. ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J. Cell Sci. 113 Pt. 22:2000;3897-3905.
15. Rivera R., Murre C. The regulation and function of the Id proteins in lymphocyte development. Oncogene. 20:2001;8308-8316.
16. Zebedee Z., Hara E. Id proteins in cell cycle control and cellular senescence. Oncogene. 20:2001;8317-8325.
17. Yokota Y., Mori S. Role of Id family proteins in growth control. J. Cell Physiol. 190:2002;21-28.
18. Murre C., Bain G., van Dijk M.A., Engel I., Furnari B.A., Massari M.E., Matthews J.R., Quong M.W., Rivera R.R., Stuiver M.H. Structure and function of helix-loop-helix proteins. Biochim. Biophys. Acta. 121B:1994;129-135.
19. Ephrussi A., Church G.M., Tonegawa S., Gilbert W. B lineage - specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science. 227:1985;134-140.
20. Benezra R., Davis R.L., Lockshon D., Turner D.L., Weintraub H. The protein Id a negative regulator of helix-loop-helix DNA binding proteins . Cell. 61:1990;49-59.
21. Ellis H.M., Spann D.R., Posakony J.W. extramacrochaetae, a negative regulator of sensory organ development in Drosophila, defines a new class of helix-loop-helix proteins. Cell. 61:1990;27-38.
22. Israel M.A., Hernandez M.C., Florio M., Andres-Barquin P.J., Mantani A., Carter J.H., Julin C.M. Id gene expression as a key mediator of tumor cell biology. Cancer Res. 59:1999;1726S-1730S.
23. Lasorella A., Uo T., Iavarone A. Id proteins at the cross-road of development and cancer. Oncogene. 20, 2001;8326-8333.
24. Watt F.M. Stem cell fate and patterning in mammalian epidermis. Curr. Opin. Genet. Dev. 11:2001;410-417.
25. Schaefer B.M., Koch J., Wirzbach A., Kramer M.D. Expression of the helix-loop-helix protein ID1 in keratinocytes is upregulated by loss of cell-matrix contact. Exp. Cell Res. 266:2001;250-259.
26. Langlands K., Down G.A., Kealey T. Id proteins are dynamically expressed in normal epidermis and dysregulated in squamous cell carcinoma. Cancer Res. 60:2000;5929-5933.
27. Alani R.M., Hasskarl J., Grace M., Hernandez M.C., Israel M.A., Munger K. Immortalization of primary human keratinocytes by the helix-loop-helix protein, Id-1. Proc. Natl. Acad. Sci. USA. 96:1999;9637-9641.
28. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., Wright W.E. Extension of life-span by introduction of telomerase into normal human cells. Science. 279:1998;349-352.
29. Nickoloff B.J., Chaturvedi V., Bacon P., Qin J.Z., Denning M.F., Diaz M.O. Id-1 delays senescence but does not immortalize keratinocytes. J. Biol. Chem. 275:2000;27501-27504.
30. Gradin K., Whitelaw M.L., Toftgard R., Poellinger L., Berghard A. A tyrosine kinase-dependent pathway regulates ligand-dependent activation of the dioxin receptor in human keratinocytes. J. Biol. Chem. 269:1994;23800-23807.
31. Prabhu S., Ignatova A., Park S.T., Sun X.H. Regulation of the expression of cyclin-dependent kinase inhibitor p21 by E2A and Id proteins. Mol. Cell. Biol. 17:1997;5888-5896.
32. el-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
33. Matsumura M.E., Lobe D.R., McNamara C.A. Contribution of the helix-loop-helix factor Id2 to regulation of vascular smooth muscle cell proliferation. J. Biol. Chem. 277:2002;7293-7297.
34. Sementchenko V.I., Watson D.K. Ets target genes past, present and future . Oncogene. 19:2000;6533-6548.
35. Li R., Pei H., Watson D.K. Regulation of Ets function by protein-protein interactions. Oncogene. 19:2000;6514-6523.
36. Prisco M., Peruzzi F., Belletti B., Baserga R. Regulation of Id gene expression by type I insulin-like growth factor roles of Stat3 and the tyrosine 950 residue of the receptor . Mol. Cell. Biol. 21:2001;5447-5458.
37. Navarro M., Valentinis B., Belletti B., Romano G., Reiss K., Baserga R. Regulation of Id2 gene expression by the type 1 IGF receptor and the insulin receptor substrate-1. Endocrinology. 142:2001;5149-5157.
38. Christy B.A., Sanders L.K., Lau L.F., Copeland N.G., Jenkins N.A., Nathans D. An Id-related helix-loop-helix protein encoded by a growth factor-inducible gene. Proc. Natl. Acad. Sci. USA. 88:1991;1815-1819.
39. Barone M.V., Pepperkok R., Peverali F.A., Philipson L. Id proteins control growth induction in mammalian cells. Proc. Natl. Acad. Sci. USA. 91:1994;4985-4988.
40. Hara E., Yamaguchi T., Nojima H., Ide T., Campisi J., Okayama H., Oda K. Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. J. Biol. Chem. 269:1994;2139-2145.
41. Belletti B., Drakas R., Morrione A., Tu X., Prisco M., Yuan T., Casaburi I., Baserga R. Regulation of Id1 protein expression in mouse embryo fibroblasts by the type 1 insulin-like growth factor receptor. Exp. Cell Res. 277:2002;107-118.
42. Liu J., Shi W., Warburton D. A cysteine residue in the helix-loop-helix domain of Id2 is critical for homodimerization and function. Biochem. Biophys. Res. Commun. 273:2000;1042-1047.
43. Minoo P., Su G., Drum H., Bringas P., Kimura S. Defects in tracheoesophageal and lung morphogenesis in Nkx2.1(-/-) mouse embryos. Dev. Biol. 209:1999;60-71.
44. Zhu W., Dahmen J., Bulfone A., Rigolet M., Hernandez M.C., Kuo W.L., Puelles L., Rubenstein J.L., Israel M.A. Id gene expression during development and molecular cloning of the human Id-1 gene. Brain Res. 30:1995;312-326.
45. Squier C.A., Kremer M.J. Biology of oral mucosa and esophagus. J. Natl. Cancer Inst. Monogr. 29:2001;7-15.
46. Y.C. Hu, K.Y. Lam, S. Law, J. Wong, G. Srivastava, Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC, Clin. Cancer Res. 7 (2001) 2213-2221.
47. Kimura Y., Shiozaki H., Doki Y., Yamamoto M., Utsunomiya T., Kawanishi K., Fukuchi N., Inoue M., Tsujinaka T., Monden M. Cytoplasmic beta-catenin in esophageal cancers. Int. J. Cancer. 20:1999;174-178.
48. Rockman S.P., Currie S.A., Ciavarella M., Vincan E., Dow C., Thomas R.J., Phillips W.A. Id2 is a target of the beta-catenin/T cell factor pathway in colon carcinoma. J. Biol. Chem. 276:2001;45113-45119.
49. Takeuchi H., Ozawa S., Ando N., Shih C.H., Koyanagi K., Ueda M., Kitajima M. Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus. Clin. Cancer Res. 3:(12 Pt 1):1997;2229-2236.
50. Yoneda K., Yokoyama T., Yamamoto T., Hatabe T., Osaki T. p53 gene mutations and p21 protein expression induced independently of p53, by TGF-beta and gamma-rays in squamous cell carcinoma cells. Eur. J. Cancer. 35:1999;278-283.
51. Wilson J.W., Deed R.W., Inoue T., Balzi M., Becciolini A., Faraoni P., Potten C.S., Norton J.D. Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index. Cancer Res. 61:2001;8803-8810.
52. Wice B.M., Gordon J.I. Forced expression of Id-1 in the adult mouse small intestinal epithelium is associated with development of adenomas. J. Biol. Chem. 273:1998;25310-25319.
53. Yan W., Young A.Z., Soares V.C., Kelley R., Benezra R., Zhuang Y. High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice. Mol. Cell. Biol. 17:1997;7317-7327.
54. Moser A.R., Pitot H.C., Dove W.F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science. 247:1990;322-324.
55. Rindi G., Ratineau C., Ronco A., Candusso M.E., Tsai M., Leiter A.B. Targeted ablation of secretin-producing cells in transgenic mice reveals a common differentiation pathway with multiple enteroendocrine cell lineages in the small intestine. Development. 126:1999;4149-4156.
56. Ratineau C., Petry M.W., Mutoh H., Leiter A.B. Cyclin D1 represses the basic helix-loop-helix transcription factor, BETA2/NeuroD. J. Biol. Chem. 277:2002;8847-8853.
57. Yang Q., Bermingham N.A., Finegold M.J., Zoghbi H.Y. Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science. 294:2001;2155-2158.
58. Lasorella A., Noseda M., Beyna M., Yokota Y., Iavarone A. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature. 407:2000;592-598.
59. Lasorella A., Boldrini R., Dominici C., Donfrancesco A., Yokota Y., Inserra A., Iavarone A. Id2 is critical for cellular proliferation and is the oncogenic effector of N-myc in human neuroblastoma. Cancer Res. 62:2002;301-306.
60. Behrens J. Control of beta-catenin signaling in tumor development. Ann. NY Acad. Sci. 10:2000;21-33.
61. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B., Kinzler K.W. Identification of c-MYC as a target of the APC pathway. Science. 281:1998;1509-1512.
62. Iavarone A., Garg P., Lasorella A., Hsu J., Israel M.A. The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein. Genes Dev. 8:1994;1270-1284.
63. Lasorella A., Iavarone A., Israel M.A. Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins. Mol. Cell. Biol. 16:1996;2570-2578.
64. Pagliuca A., Gallo P., De Luca P., Lania L. Class A helix-loop-helix proteins are positive regulators of several cyclin-dependent kinase inhibitors' promoter activity and negatively affect cell growth. Cancer Res. 60:2000;1376-1382.
65. Jensen J., Serup P., Karlsen C., Nielsen T.F., Madsen O.D. mRNA profiling of rat islet tumors reveals nkx 6.1 as a beta-cell-specific homeodomain transcription factor. J. Biol. Chem. 271:1996;18749-18758.
66. Cordle S.R., Whelan J., Henderson E., Masuoka H., Weil P.A., Stein R. Insulin gene expression in nonexpressing cells appears to be regulated by multiple distinct negative-acting control elements. Mol. Cell. Biol. 11:1991;2881-2886.
67. Robinson G.L., Cordle S.R., Henderson E., Weil P.A., Teitelman G., Stein R. Isolation and characterization of a novel transcription factor that binds to and activates insulin control element-mediated expression. Mol. Cell. Biol. 14:1994;6704-6714.
68. Qiu Y., Guo M., Huang S., Stein R. Insulin gene transcription is mediated by interactions between the p300 coactivator and PDX-1, BETA2, and E47. Mol. Cell. Biol. 22:2002;412-420.
69. Lee J.C., Smith S.B., Watada H., Lin J., Scheel D., Wang J., Mirmira R.G., German M.S. Regulation of the pancreatic pro-endocrine gene neurogenin 3. Diabetes. 50:2001;928-936.
70. Gradwohl G., Dierich A., LeMeur M., Guillemot F. Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc. Natl. Acad. Sci. USA. 97:2000;1607-1611.
71. Jensen J., Heller R.S., Funder-Nielsen T., Pedersen E.E., Lindsell C., Weinmaster G., Madsen O.D., Serup P. Independent development of pancreatic alpha- and beta-cells from neurogenin3-expressing precursors a role for the notch pathway in repression of premature differentiation . Diabetes. 49:2000;163-176.
72. Jensen J., Pedersen E.E., Galante P., Hald J., Heller R.S., Ishibashi M., Kageyama R., Guillemot F., Serup P., Madsen O.D. Control of endodermal endocrine development by Hes-1. Nat. Genet. 24:2000;36-44.
73. Krapp A., Knofler M., Ledermann B., Burki K., Berney C., Zoerkler N., Hagenbuchle O., Wellauer P.K. The bHLH protein PTF1-p48 is essential for the formation of the exocrine and the correct spatial organization of the endocrine pancreas. Genes Dev. 12:1998;3752-3763.
74. Rose S.D., Swift G.H., Peyton M.J., Hammer R.E., MacDonald R.J. The role of PTF1-P48 in pancreatic acinar gene expression. J. Biol. Chem. 276:2001;44018-44026.
75. Biankin A.V., Kench J.G., Morey A.L., Lee C.S., Biankin S.A., Head D.R., Hugh T.B., Henshall S.M., Sutherland R.L. Overexpression of p21 (WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia. Cancer Res. 61:2001;8830-8837.
76. Peverali F.A., Ramqvist T., Saffrich R., Pepperkok R., Barone M.V., Philipson L. Regulation of G1 progression by E2A and Id helix-loop-helix proteins. EMBO J. 13:1994;4291-4301.
77. Warshaw A.L., Fernandez-del Castillo C. Pancreatic carcinoma. N. Engl. J. Med. 326:1992;455-465.
78. Kleef F.J., Ishiwata T., Friess H., Buchler M.W., Israel M.A., Korc M. The helix-loop-helix protein Id2 is overexpressed in human pancreatic cancer. Cancer Res. 58:1998;3769-3772.
79. Maruyama H., Kleeff J., Wildi S., Friess H., Buchler M.W., Israel M.A., Korc M. Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis. Am. J. Pathol. 155:1999;815-822.
80. Le Jossic C., Ilyin G.P., Loyer P., Glaise D., Cariou S., Guguen-Guillouzo C. Expression of helix-loop-helix factor Id-1 is dependent on the hepatocyte proliferation and differentiation status in rat liver and in primary culture. Cancer Res. 54:1994;6065-6068.
81. Vincent K.J., Jones E., Arthur M.J., Smart D.E., Trim J., Wright M.C., Mann D.A. Regulation of E-box DNA binding during in vivo and in vitro activation of rat and human hepatic stellate cells. Gut. 49:2001;713-719.
82. Terai S., Aoki H., Ashida K., Thorgeirsson S.S. Human homologue of maid A dominant inhibitory helix-loop-helix protein associated with liver-specific gene expression . Hepatology. 32:2000;357-366.
83. Hwang S.Y., Oh B., Fuchtbauer A., Fuchtbauer E.M., Johnson K.R., Solter D., Knowles B.B. Maid a maternally transcribed novel gene encoding a potential negative regulator of bHLH proteins in the mouse egg and zygote . Dev. Dyn. 209:1997;217-226.
84. Kebebew E., Treseler P.A., Duh Q.Y., Clark O.H. The helix-loop-helix transcription factor, Id-1, is overexpressed in medullary thyroid cancer. Surgery. 128:2000;952-957.
85. Marsh D.J., Learoyd D.L., Robinson B.G. Medullary thyroid carcinoma recent advances and management update . Thyroid. 5:1995;407-424.
86. Chen H., Carson-Walter E.B., Baylin S.B., Nelkin B.D., Ball D.W. Differentiation of medullary thyroid cancer by C-Raf-1 silences expression of the neural transcription factor human achaete-scute homolog-1. Surgery. 120:1996;168-172.
87. Riechmann V., van Cruchten I., Sablitzky F. The expression pattern of Id4, a novel dominant negative helix-loop-helix protein, is distinct from Id1, Id2 and Id3. Nucleic Acids Res. 22:1994;749-755.
88. van Cruchten I., Cinato E., Fox M., King E.R., Newton J.S., Riechmann V., Sablitzky F. Structure, chromosomal localisation and expression of the murine dominant negative helix-loop-helix Id4 gene. Biochim. Biophys. Acta. 1443:1998;55-64.
89. Hernandez M.C., Andres-Barquin P.J., Israel M.A. Molecular cloning of the cDNA encoding a helix-loop-helix protein, mouse ID1B tissue-specific expression of ID1A and ID1B genes . Biochim. Biophys. Acta. 308:1996;28-30.
90. Krieg M., Haas R., Brauch H., Acker T., Flamme I., Plate K.H. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene. 19:2000;5435-5443.
91. Ivanova A.V., Ivanov S.V., Danilkovitch-Miagkova A., Lerman M.I. Regulation of STRA13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the UBC9/ubiquitin proteasome degradation pathway. J. Biol. Chem. 276:2001;15306-15315.
92. Hara S., Hamada J., Kobayashi C., Kondo Y., Imura N. Expression and characterization of hypoxia-inducible factor (HIF)-3alpha in human kidney suppression of HIF-mediated gene expression by HIF-3alpha . Biochem. Biophys. Res. Commun. 287:2001;808-813.
93. Maltepe E., Keith B., Arsham A.M., Brorson J.R., Simon M.C. The role of ARNT2 in tumor angiogenesis and the neural response to hypoxia. Biochem. Biophys. Res. Commun. 273:2000;231-238.
94. Keith B., Adelman D.M., Simon M.C. Targeted mutation of the murine arylhydrocarbon receptor nuclear translocator 2 (Arnt2) gene reveals partial redundancy with Arnt. Proc. Natl. Acad. Sci. USA. 98:2001;6692-6697.
95. Imabayashi T., Iehara N., Takeoka H., Uematsu-Yanagita M., Kataoka H., Nishikawa S., Sano H., Yokode M., Fukatsu A., Kita T., Doi T. Expression of basic helix-loop-helix proteins in the glomeruli. Clin. Nephrol. 55:2001;53-58.
96. Quaggin S.E., Schwartz L., Cui S., Igarashi P., Deimling J., Post M., Rossant J. The basic-helix-loop-helix protein pod1 is critically important for kidney and lung organogenesis. Development. 126:1999;5771-5783.
97. Whyte D.A., Li C., Thomson R.B., Nix S.L., Zanjani R., Karp S.L., Aronson P.S., Igarashi P. Ksp-cadherin gene promoter. I. Characterization and renal epithelial cell-specific activity. Am. J. Physiol. 277:1999;F587-F598.
98. Gould S.E., Day M., Jones S.S., Dorai H. BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidney Int. 61:2002;51-60.
99. Sciarra F., Toscano V. Role of estrogens in human benign prostatic hyperplasia. Arch. Androl. 44:2000;213-220.
100. Ouyang X.S., Wang X., Lee D.T., Tsao S.W., Wong Y.C. Up-regulation of TRPM-2, MMP-7 and ID-1 during sex hormone-induced prostate carcinogenesis in the Noble rat. Carcinogenesis. 22:2001;965-973.
101. Ouyang X.S., Wang X., Lee D.T., Tsao S.W., Wong Y.C. Over expression of ID-1 in prostate cancer. J. Urol. 167:2002;2598-2602.
102. Ling M.T., Wang X., Tsao S.W., Wong Y.C. Down-regulation of Id-1 expression is associated with TGFbeta1-induced growth arrest in prostate epithelial cells. Biochim. Biophys. Acta. 1570:2002;145-152.
103. Goumans M.J., Valdimarsdottir G., Itoh S., Rosendahl A., Sideras P., ten Dijke P. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J. 21:2002;1743-1753.
104. Hollnagel A., Oehlmann V., Heymer J., Ruther U., Nordheim A. Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J. Biol. Chem. 274:1999;19838-19845.
105. Korchynskyi O., ten Dijke P. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J. Biol. Chem. 277:2002;4883-4891.
106. Ouyang X.S., Wang X., Ling M.T., Wong H.L., Tsao S.W., Wong Y.C. Id-1 stimulates serum independent prostate cancer cell proliferation through inactivation of p16(INK4a)/pRB pathway. Carcinogenesis. 23:2002;721-725.
107. Polsky D., Young A.Z., Busam K.J., Alani R.M. The transcriptional repressor of p16/Ink4a, Id1, is up-regulated in early melanomas. Cancer Res. 61:2001;6008-6011.
108. Knox J.D., Wolf C., McDaniel K., Clark V., Loriot M., Bowden G.T., Nagle R.B. Matrilysin expression in human prostate carcinoma. Mol. Carcinog. 15:1996;57-63.
109. Steinberg J., et al. Intracellular levels of SGP-2 (Clusterin) correlate with tumor grade in prostate cancer. Clin. Cancer Res. 3:1997;1707-1711.
110. Chetcuti A., Margan S., Mann S., Russell P., Handelsman D., Rogers J., Dong Q. Identification of differentially expressed genes in organ-confined prostate cancer by gene expression array. Prostate. 47:2001;132-140.
111. Ernst T., Hergenhahn M., Kenzelmann M., Cohen C.D., Bonrouhi M., Weninger A., Klaren R., Grone E.F., Wiesel M., Gudemann C., Kuster J., Schott W., Staehler G., Kretzler M., Hollstein M., Grone H.J. Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma a gene expression analysis on total and microdissected prostate tissue . Am. J. Pathol. 60:2002;2169-2180.
112. Chaudhary J., Kim G., Skinner M.K. Expression of the basic helix-loop-helix protein REBalpha in rat testicular Sertoli cells. Biol Reprod. 60:1999;1244-1250.
113. Chaudhary J., Mosher R., Kim G., Skinner M.K. Role of winged helix transcription factor (WIN) in the regulation of Sertoli cell differentiated functions WIN acts as an early event gene for follicle-stimulating hormone . Endocrinology. 141:2000;2758-2766.
114. Sablitzky F., Moore A., Bromley M., Deed R.W., Newton J.S., Norton J.D. Stage- and subcellular-specific expression of Id proteins in male germ and Sertoli cells implicates distinctive regulatory roles for Id proteins during meiosis, spermatogenesis, and Sertoli cell function. Cell Growth Differ. 9:1998;1015-1024.
115. Chaudhary J., Skinner M.K. E-box and cyclic adenosine monophosphate response elements are both required for follicle-stimulating hormone-induced transferrin promoter activation in Sertoli cells. Endocrinology. 140:1999;1262-1271.
116. Daggett M.A., Rice D.A., Heckert L.L. Expression of steroidogenic factor 1 in the testis requires an E box and CCAAT box in its promoter proximal region. Biol. Reprod. 62:2000;670-679.
117. Goetz T.L., Lloyd T.L., Griswold M.D. Role of E box and initiator region in the expression of the rat follicle-stimulating hormone receptor. J. Biol. Chem. 271:1996;33317-33324.
118. Chaudhary J., Skinner M.K. Identification of a novel gene product, Sertoli cell gene with a zinc finger domain, that is important for FSH activation of testicular Sertoli cells. Endocrinology. 143:2002;426-435.
119. Takai N., Miyazaki T., Fujisawa K., Nasu K., Miyakawa I. Id1 expression is associated with histological grade and invasive behavior in endometrial carcinoma. Cancer Lett. 165:2001;185-193.
120. Schindl M., Oberhuber G., Obermair A., Schoppman S.F., Karner B., Birner P. Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. Cancer Res. 61:2001;5703-5706.
121. Arnold J.M., Cummings M., Purdie D., Chenevix-Trench G. Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas. Br. J. Cancer. 85:2001;1351-1358.
122. Beger C., Pierce L.N., Kruger M., Marcusson E.G., Robbins J.M., Welcsh P., Welch P.J., Welte K., King M.C., Barber J.R., Wong-Staal F. Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach. Proc. Natl. Acad. Sci. USA. 98:2001;130-135.
123. Prall O.W., Rogan E.M., Musgrove E.A., Watts C.K., Sutherland R.L. c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry. Mol. Cell. Biol. 18:1998;4499-4508.
124. Wang Q., Zhang H., Kajino K., Greene M.I. BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells. Oncogene. 17:1998;1939-1948.
125. Parrinello S., Lin C.Q., Murata K., Itahana Y., Singh J., Krtolica A., Campisi J., Desprez P.Y. Id-1, ITF-2, and Id-2 comprise a network of helix-loop-helix proteins that regulate mammary epithelial cell proliferation, differentiation, and apoptosis. J. Biol. Chem. 276:2001;39213-39219.
126. Desprez P.Y., Hara E., Bissell M.J., Campisi J. Suppression of mammary epithelial cell differentiation by the helix-loop-helix protein Id-1. Mol. Cell Biol. 15:1995;3398-3404.
127. Schmidhauser C., Bissell M.J., Myers C.A., Casperson G.F. Extracellular matrix and hormones transcriptionally regulate bovine beta-casein 5′sequences in stably transfected mouse mammary cells. Proc. Natl. Acad. Sci. USA. 87:1990;9118-9122.
128. Roskelley C.D., Desprez P.Y., Bissell M.J. Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction. Proc. Natl. Acad. Sci. USA. 91:1994;12378-12382.
129. Singh J., Itahana Y., Parrinello S., Murata K., Desprez P.Y. Molecular cloning and characterization of a zinc finger protein involved in Id-1-stimulated mammary epithelial cell growth. J. Biol. Chem. 276:2001;11852-11858.
130. Desprez P.Y., Lin C.Q., Thomasset N., Sympson C.J., Bissell M.J., Campisi J. A novel pathway for mammary epithelial cell invasion induced by the helix-loop-helix protein Id-1. Mol. Cell. Biol. 18:1998;4577-4588.
131. Woo P., Cercek A., Desprez P.Y., Firestone G.L. Involvement of the helix-loop-helix protein Id-1 in the glucocorticoid regulation of tight junctions in mammary epithelial cells. J. Biol. Chem. 275:2000;28649-28658.
132. Mori S., Nishikawa S.I., Yokota Y. Lactation defect in mice lacking the helix-loop-helix inhibitor Id2. EMBO J. 19:2000;5772-5781.
133. Lin C.Q., Singh J., Murata K., Itahana Y., Parrinello S., Liang S.H., Gillett C.E., Campisi J., Desprez P.Y. A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. Cancer Res. 60:2000;1332-1340.
134. Singh J., Murata K., Itahana Y., Desprez P.Y. Constitutive expression of the Id-1 promoter in human metastatic breast cancer cells is linked with the loss of NF-1/Rb/HDAC-1 transcription repressor complex. Oncogene. 21:2002;1812-1822.
135. Tournay O., Benezra R. Transcription of the dominant-negative helix-loop-helix protein Id1 is regulated by a protein complex containing the immediate-early response gene Egr-1. Mol. Cell. Biol. 16:1996;2418-2430.
136. Akhurst R.J., Derynck R. TGF-beta signaling in cancer - a double-edged sword. Trends Cell. Biol. 11:2001;S44-S51.
137. Clement J.H., Marr N., Meissner A., Schwalbe M., Sebald W., Kliche K.O., Hoffken K., Wolfe S. Bone morphogenetic protein 2 (BMP-2) induces sequential changes of Id gene expression in the breast cancer cell line MCF-7. J. Cancer Res. Clin. Oncol. 126:2000;271-279.
138. Ogata T., Wozney J.M., Benezra R., Noda M. Bone morphogenetic protein 2 transiently enhances expression of a gene, Id (inhibitor of differentiation), encoding a helix-loop-helix molecule in osteoblast-like cells. Proc. Natl. Acad. Sci. USA. 90:1993;9219-9222.
139. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., Rosen V., Wozney J.M., Fujisawa-Sehara A., Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 127:1994;1755-1761.
140. Lopez-Rovira T., Chalaux E., Massague J., Rosa J.L., Ventura F. Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene. J. Biol. Chem. 277:2002;3176-3185.
141. Kolligs F.T., Nieman M.T., Winer I., Hu G., van Mater D., Feng Y., Smith I.M., Wu R., Zhai Y., Cho K.R., Fearon E.R. ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation. Cancer Cell. 1:2002;145-155.
142. Baonza A., Casci T., Freeman M. A primary role for the epidermal growth factor receptor in ommatidial spacing in the Drosophila eye. Curr. Biol. 11:2001;396-404.
143. Planque N., Leconte L., Coquelle F.M., Martin P., Saule S. Specific Pax-6/microphthalmia transcription factor interactions involve their DNA-binding domains and inhibit transcriptional properties of both proteins. J. Biol. Chem. 276:2001;29330-29337.
144. Tachibana M. MITF a stream flowing for pigment cells . Pigment Cells Res. 13:2000;230-240.
145. Galibert M.D., Carreira S., Goding C.R. The Usf-1 transcription factor is a novel target for the stress-responsive p38 kinase and mediates UV-induced tyrosinase expression. EMBO J. 20:2001;5022-5031.
146. Makino Y., Cao R., Svensson K., Bertilsson G., Asman M., Tanaka H., Cao Y., Berkenstam A., Poellinger L. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature. 414:2001;550-554.
147. Kopan R., Weintraub H. Mouse notch expression in hair follicles correlates with cell fate determination . J. Cell Biol. 121:1993;631-641.
148. Liu M., Pereira F.A., Price S.D., Chu M.J., Shope C., Himes D., Eatock R.A., Brownell W.E., Lysakowski A., Tsai M.J. Essential role of BETA2/NeuroD1 in development of the vestibular and auditory systems. Genes Dev. 14:2000;2839-2854.
149. Nibu K., Kondo K., Ohta Y., Ishibashi T., Rothstein J.L., Kaga K. Expression of NeuroD and TrkB in developing and aged mouse olfactory epitheliu. Neuroreport. 12:2001;1615-1619.
150. Cau E., Gradwohl G., Casarosa S., Kageyama R., Guillemot F. Hes genes regulate sequential stages of neurogenesis in the olfactory epithelium. Development. 127:2000;2323-2332.
151. Lemercier C., To R.Q., Swanson B.J., Lyons G.E., Konieczny S.F. Mist1 a novel basic helix-loop-helix transcription factor exhibits a developmentally regulated expression pattern . Dev. Biol. 182:1997;101-113.
152. Pin C.L., Bonvissuto A.C., Konieczny S.F. Mist1 expression is a common link among serous exocrine cells exhibiting regulated exocytosis. Anat. Rec. 259:2000;157-167.
153. Lu J., Chang P., Richardson J.A., Gan L., Weiler H., Olson E.N. The basic helix-loop-helix transcription factor capsulin controls spleen organogenesis. Proc. Natl. Acad. Sci. USA. 97:2000;9525-9530.
154. Wice B.M., Bernal-Mizrachi E., Permutt M.A. Glucose and other insulin secretagogues induce, rather than inhibit, expression of Id-1 and Id-3 in pancreatic islet beta cells. Diabetologia. 44:2001;453-463.
155. Perez-Moreno M.A., Locascio A., Rodrigo I., Dhondt G., Portillo F., Nieto M.A., Cano A. A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions. J. Biol. Chem. 276:2001;27424-27431.
156. Hegerfeldt Y., Tusch M., Brocker E.B., Friedl P. Collective cell movement in primary melanoma explants plasticity of cell-cell interaction, beta1-integrin function, and migration strategies . Cancer Res. 62:2002;2125-2130.